OHR Pharmaceutical Inc.

Profile

Business Description

Ohr Pharmaceutical Inc. is a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets. The Company is focused on advancing its pipeline products currently in Phase 2 clinical development: Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration, and OHR/AVR118 for the treatment of cancer cachexia. 

Address:
800 Third Avenue
11th Floor
New York, NY 10022

Email:
info@ohrpharmaceutical.com

Telephone:
212-682-8452

Fax:
212-644-0544

Details

CEO:
Jason Slakter M.D.

Issue Type:
Common Stock

Auditors:
MaloneBailey LLP

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

Sub-Industry:
Biotechnology

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)